News from contractpharma.comFollowNews from contractpharma.comAll of today’s top news stories from contractpharma.com. Get the full analysis behind how media bias impacts breaking news.Ground News has come across 309 headlines reported on by contractpharma.com during the past 3 months. contractpharma.com’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is contractpharma.com credible or reliable? Our Factuality score answers both of those questions. When it comes to contractpharma.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.Follow All of today’s top news stories from contractpharma.com. Get the full analysis behind how media bias impacts breaking news. Ground News has come across 309 headlines reported on by contractpharma.com during the past 3 months. contractpharma.com’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is contractpharma.com credible or reliable? Our Factuality score answers both of those questions. When it comes to contractpharma.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check. Information about contractpharma.comWhere is contractpharma.com located?contractpharma.com's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top contractpharma.com NewsStock Markets · JapanKura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - Kura Oncology (NASDAQ:KURA)67% Center coverage: 3 sources– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead U.S. development and commercial activities and book sales; Kyowa Kirin has exclusive commercialization rights outside the U.S. – – Companies to jointly…See the StoryMedical · GermanyHalozyme drops Evotec buyout bid; Patient dies in Neurogene trial100% Center coverage: 1 sourcesEvotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target in sight and an FDA veteran plans retirement.See the StorySanta Monica · Santa MonicaHealthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Acquires Technologies From ClearlakeArlington Capital Partners has announced its acquisition of TEAM Technologies from Clearlake Capital Group. TEAM Tech, founded in 1988 and based in Morristown, Tennessee, is a manufacturing solutions provider for medical and dental products. Arlington Capital, founded in 1999 and based in Washington, D.C., is a private equity firm specializing in government-regulated industries, including healthcare. Clearlake, founded in 2006 and based in Santa…See the StoryLatest News StoriesTopics Most Covered by contractpharma.comCancerVaccinesMerckAstraZenecaArtificial IntelligenceCancerVaccinesMerckSources Covering Similar Topicsstocktitan.netGEN - Genetic Engineering and Biotechnology News…pharmaceutical-technology.comcitybizpipelinereviewstocktitan.netGEN - Genetic Engineering and Biotechnology News…pharmaceutical-technology.comSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
